Based on the present study, we confirmed that baicalein pretreatment suppresses Ang II-induced AAA formation in mice, particularly via VSMC phenotypic alleviation of oxidative stress by activating the NF-κB/NLRP3 inflammasome signaling pathways (Figure 7). The gene discussed is NFKB1; the disease is triple-A syndrome.